Linda Moore | General Counsel |
Pam Marrone | CEO |
Jim Boyd | President and CFO |
Kevin Hammill | Chief Commercial Officer |
Sameer Joshi | H.C. Wainwright |
Ben Klieve | National Securities |
Laurence Alexander | Jefferies |
Ian Gilson | Zacks Investment Research |
Good day, everyone and welcome to the Marrone Bio Innovations Third Quarter 2019 Earnings Conference. Today's call is being recorded. At this time, I would like to turn the conference over to Ms. Linda Moore, General Counsel. Please go ahead.